Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

17 trials with published results (22%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

3.9%

3 terminated out of 76 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

7%

5 trials in Phase 3/4

Results Transparency

52%

17 of 33 completed with results

Key Signals

17 with results92% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (26)
P 1 (5)
P 2 (18)
P 3 (2)
P 4 (3)

Trial Status

Completed33
Unknown11
Recruiting10
Active Not Recruiting9
Not Yet Recruiting5
Terminated3

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (76)

Showing 20 of 20 trials
NCT07553663Phase 1Not Yet Recruiting

Evaluating the Pharmacokinetics and Safety of Miricorilant

NCT07265544Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

NCT06218589Not ApplicableActive Not Recruiting

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

NCT05384652Active Not RecruitingPrimary

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

NCT06947304Phase 1Recruiting

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

NCT06477146Phase 2RecruitingPrimary

Milk Thistle Clinical Trial in Pediatric NAFLD

NCT07268937CompletedPrimary

Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices

NCT02754037Active Not RecruitingPrimary

Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

NCT04835831Not ApplicableActive Not RecruitingPrimary

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease

NCT04820036Not ApplicableActive Not Recruiting

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

NCT02037321Active Not Recruiting

Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk

NCT06626074Not ApplicableRecruitingPrimary

Exploratory Study of MRI Biomarkers of NASH

NCT05051527CompletedPrimary

Study to Evaluate the Effectiveness of Legalon®

NCT07180745Phase 4Not Yet RecruitingPrimary

Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

NCT07172997Active Not Recruiting

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

NCT06727279Not ApplicableNot Yet RecruitingPrimary

Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease

NCT06024408Phase 1CompletedPrimary

A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

NCT07093346Not ApplicableRecruiting

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT07068191Not ApplicableRecruiting

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

NCT06942312Enrolling By InvitationPrimary

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Scroll to load more

Research Network

Activity Timeline